255 related articles for article (PubMed ID: 35217403)
1. Development of an in vitro model for animal species susceptibility to SARS-CoV-2 replication based on expression of ACE2 and TMPRSS2 in avian cells.
Kapczynski DR; Sweeney R; Spackman E; Pantin-Jackwood M; Suarez DL
Virology; 2022 Apr; 569():1-12. PubMed ID: 35217403
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 utilization of ACE2 from different bat species allows for virus entry and replication in vitro.
Briggs K; Sweeney R; Blehert DS; Spackman E; Suarez DL; Kapczynski DR
Virology; 2023 Sep; 586():122-129. PubMed ID: 37542819
[TBL] [Abstract][Full Text] [Related]
3. Evaluating angiotensin-converting enzyme 2-mediated SARS-CoV-2 entry across species.
Zhang HL; Li YM; Sun J; Zhang YY; Wang TY; Sun MX; Wang MH; Yang YL; Hu XL; Tang YD; Zhao J; Cai X
J Biol Chem; 2021; 296():100435. PubMed ID: 33610551
[TBL] [Abstract][Full Text] [Related]
4. A Newly Engineered A549 Cell Line Expressing ACE2 and TMPRSS2 Is Highly Permissive to SARS-CoV-2, Including the Delta and Omicron Variants.
Chang CW; Parsi KM; Somasundaran M; Vanderleeden E; Liu P; Cruz J; Cousineau A; Finberg RW; Kurt-Jones EA
Viruses; 2022 Jun; 14(7):. PubMed ID: 35891350
[TBL] [Abstract][Full Text] [Related]
5. Species-Specific Molecular Barriers to SARS-CoV-2 Replication in Bat Cells.
Aicher SM; Streicher F; Chazal M; Planas D; Luo D; Buchrieser J; Nemcova M; Seidlova V; Zukal J; Serra-Cobo J; Pontier D; Pain B; Zimmer G; Schwartz O; Roingeard P; Pikula J; Dacheux L; Jouvenet N
J Virol; 2022 Jul; 96(14):e0060822. PubMed ID: 35862713
[TBL] [Abstract][Full Text] [Related]
6. Differential susceptibility of SARS-CoV-2 in animals: Evidence of ACE2 host receptor distribution in companion animals, livestock and wildlife by immunohistochemical characterisation.
Lean FZX; Núñez A; Spiro S; Priestnall SL; Vreman S; Bailey D; James J; Wrigglesworth E; Suarez-Bonnet A; Conceicao C; Thakur N; Byrne AMP; Ackroyd S; Delahay RJ; van der Poel WHM; Brown IH; Fooks AR; Brookes SM
Transbound Emerg Dis; 2022 Jul; 69(4):2275-2286. PubMed ID: 34245662
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 and SARS-CoV Spike-Mediated Cell-Cell Fusion Differ in Their Requirements for Receptor Expression and Proteolytic Activation.
Hörnich BF; Großkopf AK; Schlagowski S; Tenbusch M; Kleine-Weber H; Neipel F; Stahl-Hennig C; Hahn AS
J Virol; 2021 Apr; 95(9):. PubMed ID: 33608407
[TBL] [Abstract][Full Text] [Related]
8. ACE2 and TMPRSS2 distribution in the respiratory tract of different animal species and its correlation with SARS-CoV-2 tissue tropism.
Carossino M; Izadmehr S; Trujillo JD; Gaudreault NN; Dittmar W; Morozov I; Balasuriya UBR; Cordon-Cardo C; García-Sastre A; Richt JA
Microbiol Spectr; 2024 Feb; 12(2):e0327023. PubMed ID: 38230954
[TBL] [Abstract][Full Text] [Related]
9.
Kumar A; Panwar A; Batra K; De S; Maan S
Comb Chem High Throughput Screen; 2021; 24(10):1769-1783. PubMed ID: 33172369
[TBL] [Abstract][Full Text] [Related]
10. Mutations derived from horseshoe bat ACE2 orthologs enhance ACE2-Fc neutralization of SARS-CoV-2.
Mou H; Quinlan BD; Peng H; Liu G; Guo Y; Peng S; Zhang L; Davis-Gardner ME; Gardner MR; Crynen G; DeVaux LB; Voo ZX; Bailey CC; Alpert MD; Rader C; Gack MU; Choe H; Farzan M
PLoS Pathog; 2021 Apr; 17(4):e1009501. PubMed ID: 33836016
[TBL] [Abstract][Full Text] [Related]
11. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional modelling of SARS-CoV-2 entry in animal models.
Brooke GN; Prischi F
Sci Rep; 2020 Sep; 10(1):15917. PubMed ID: 32985513
[TBL] [Abstract][Full Text] [Related]
13. Little Brown Bats (
Chothe SK; Jakka P; Boorla VS; Ramasamy S; Gontu A; Nissly RH; Brown J; Turner G; Sewall BJ; Reeder DM; Field KA; Engiles JB; Amirthalingam S; Ravichandran A; LaBella L; Nair MS; Maranas CD; Kuchipudi SV
Viruses; 2023 Apr; 15(5):. PubMed ID: 37243189
[TBL] [Abstract][Full Text] [Related]
14. Molecular evolution and phylogenetic analysis of SARS-CoV-2 and hosts ACE2 protein suggest Malayan pangolin as intermediary host.
Lopes LR; de Mattos Cardillo G; Paiva PB
Braz J Microbiol; 2020 Dec; 51(4):1593-1599. PubMed ID: 32592038
[TBL] [Abstract][Full Text] [Related]
15. Highly Efficient SARS-CoV-2 Infection of Human Cardiomyocytes: Spike Protein-Mediated Cell Fusion and Its Inhibition.
Navaratnarajah CK; Pease DR; Halfmann PJ; Taye B; Barkhymer A; Howell KG; Charlesworth JE; Christensen TA; Kawaoka Y; Cattaneo R; Schneider JW;
J Virol; 2021 Nov; 95(24):e0136821. PubMed ID: 34613786
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
[TBL] [Abstract][Full Text] [Related]
17. Variation in the ACE2 receptor has limited utility for SARS-CoV-2 host prediction.
Mollentze N; Keen D; Munkhbayar U; Biek R; Streicker DG
Elife; 2022 Nov; 11():. PubMed ID: 36416537
[TBL] [Abstract][Full Text] [Related]
18. Comparative analyses of ACE2 and TMPRSS2 gene: Implications for the risk to which vertebrate animals are susceptible to SARS-CoV-2.
Huang C; Jiang Y; Yan J
J Med Virol; 2021 Sep; 93(9):5487-5504. PubMed ID: 33974296
[TBL] [Abstract][Full Text] [Related]
19. The TMPRSS2 Inhibitor Nafamostat Reduces SARS-CoV-2 Pulmonary Infection in Mouse Models of COVID-19.
Li K; Meyerholz DK; Bartlett JA; McCray PB
mBio; 2021 Aug; 12(4):e0097021. PubMed ID: 34340553
[TBL] [Abstract][Full Text] [Related]
20. The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression.
Pivniouk V; Pivniouk O; DeVries A; Uhrlaub JL; Michael A; Pivniouk D; VanLinden SR; Conway MY; Hahn S; Malone SP; Ezeh P; Churko JM; Anderson D; Kraft M; Nikolich-Zugich J; Vercelli D
J Allergy Clin Immunol; 2022 Mar; 149(3):923-933.e6. PubMed ID: 34902435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
